A Ten Pas - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Ten Pas

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Canadian Medical Association Journal|March 24, 2010

Methyldopa-induced thrombocytopeniaA Ten Pas, N K de Leeuw, C H Stacey

Hemoglobin|January 1, 1977

Hb Vaasa or alpha2beta2 (39(C5)Gln replaced by Glu), a mildly unstable variant found in a Finnish familyA G Kendall, A ten Pas, J B Wilson, et al.

Cancer Chemotherapy Reports|August 1, 1972

Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemiaR R Ellison, B Hoogstraten, J F Holland, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Canadian Medical Association Journal|March 24, 2010

Methyldopa-induced thrombocytopeniaA Ten Pas, N K de Leeuw, C H Stacey

Hemoglobin|January 1, 1977

Hb Vaasa or alpha2beta2 (39(C5)Gln replaced by Glu), a mildly unstable variant found in a Finnish familyA G Kendall, A ten Pas, J B Wilson, et al.

Cancer Chemotherapy Reports|August 1, 1972

Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemiaR R Ellison, B Hoogstraten, J F Holland, et al.

Pageof 1